Silence Therapeutics (SLN) - Uzoq muddatli qarzning kapitalga nisbati
Silence Therapeutics (SLN) yurak va qon terapiyasi uchun innovatsion dori vositalarini ishlab chiqishga ixtisoslashgan. Ushbu narxlar grafigi aktiv dinamikasini aks ettiradi, bunda ko'rsatkich 0.00 darajasida turibdi. Biznes logistikani optimallashtirish uchun dori ishlab chiqarish va sinovlarini tashqi pudratchilarga topshiradi. Strategiya RNK interferentsiyasiga asoslanadi, bozor yetakchilari bilan hamkorlik esa moliyaviy yo'qotishlarni kamaytiradi. Global litsenziyalar orqali portfelni tasdiqlash texnologik risklarni minimallashtiradi.
%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_SLN_-_Silence-Therapeutics_-_Long-Term-Debt-to-Equity "silence-therapeutics.com (SLN): Uzoq muddatli qarzdorlikning kapitalga nisbati 21.06.2023dan 31.10.2026gacha | 👁️GURU.Markets👁️")
Silence Therapeutics (SLN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- kompaniyaning balans qiymati tafsilotlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning xususiy kapitalga nisbati Silence Therapeutics|SLN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati silence-therapeutics.com|SLN - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Silence Therapeutics plc|SLN - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Silence Therapeutics|Shoshilinch likvidlik silence-therapeutics.com
- foyda va bozor multiplikatorlari tafsilotlari:
Kompaniyaning har tomonlama tahlili:Silence Therapeutics PLC SLN
Ushbu ko'rsatkich yashirin leveraj xatarlarini aniqlash uchun bir yildan ortiq muddatli majburiyatlarni kapital bilan solishtirish orqali moliyaviy barqarorlikni baholaydi. Uzoq muddatli kreditlarning kapitalga nisbatini tahlil qilish orqali investor Silence Therapeutics (SLN) kompaniyasining tashqi moliyalashtirishga bog'liqlik darajasini aniqlashi mumkin, bu esa bevosita narx belgilash imkoniyati yo'qligida daromadlari faqat litsenziyalash to'lovlari bilan cheklangan biotexnologiya firmasi uchun juda muhimdir.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning kapitalga nisbati QGEN|Uzoq muddatli qarzning kapitalga nisbati Isis Pharmaceuticals (IONS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Repligen Corporation RGEN|Uzoq muddatli qarzdorlikning kapitalga nisbati aviditybiosciences.com (RNA)|CRISPR Therapeutics - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati GeneDx Holdings WGS|Ultragenyx Pharma (RARE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BEAM (Beam Tx) - Uzoq muddatli qarzning o'z kapitaliga nisbati|SRPT (Sarepta Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati twistbioscience.com TWST|Uzoq muddatli qarzning o'z kapitaliga nisbati 10x Genomics (TXG)|Intellia Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati STOK (Stoke)|BLFS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Wave Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati mazetx.com|SION (Sionna Therapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Prime Medicine Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati TSHA|QURE (uniQure Pharma) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati MGTX|RGNX (regenxbio.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati SLDB (Solid Biosciences)|Ocugen Inc (OCGN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PACB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti BNTC (Benitec Corp)|DSGN: Uzoq muddatli qarzning kapitalga nisbati|rocketpharma.com (RCKT) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati 4D Molecular Therapeutics, Inc.|Lexeo - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati KRRO|EDIT - Uzoq muddatli majburiyatlarning kapitalga nisbati|ProQR Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Codexis Inc CDXS|SGMO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Nautilus Biotechnology - Uzoq muddatli kreditlarning kapitalga nisbati|MGX: Uzoq muddatli qarzning kapitalga nisbati|DTIL - Uzoq muddatli qarzdorlikning kapitalga nisbati|GBIO (Generation Bio Co) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati boundlessbio.com (BOLD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Exicure, Inc. (XCUR)|Uzoq muddatli qarzdorlikning kapitalga nisbati imunon.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Phio Pharmaceuticals Corp. PHIO|Uzoq muddatli qarzdorlikning kapitalga nisbati Mustang Bio Inc (MBIO)|RNAZ - Uzoq muddatli qarzning o'z kapitaliga nisbati|BNGO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Applied DNA Sciences, Inc. (APDN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BLUE|IPA (ImmunoPrecise Antibodies Ltd) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMGA (Omega Therapeutics Corp)|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems (OMIC)|regulusrx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati SYRS (Syros Pharmaceuticals, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Telesis Bio Inc. TBIO|TCON - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Unity Biotechnology, Inc UBX